Meg is a communications consultant on the speed-dials of countless healthcare C-Suite executives. Over nearly 15 years, she has helped Fortune 500 companies successfully navigate some of the most challenging issues facing their industries – tackling issues involving the affordability of medicines, recalls, compassionate use campaigns, lawsuits, activist attacks and more. Meg’s areas of expertise include addressing forms of modern activism, navigating new populism, and helping healthcare companies avoid drug pricing crises. Her passionate advocacy for her clients and innovative approach have secured recognitions of as a “Disruptor” and a “Rising Star” by PM360 and the Healthcare Business Women’s Association.
Biosector 2 is part of Syneos Health Communications, the only healthcare communications network that is part of a company on the frontlines of healthcare. Our advertising, public relations, medical communications, digital, data science, research and market access specialists have the ability to tap the expertise of clinical and commercial colleagues worldwide to infuse programs with deep therapeutic and analytic insights. We work in scalable, collaborative teams that partner across disciplines and geographies to deliver integrated communications strategies that accelerate brand performance.